Patents by Inventor Andrew Kennedy

Andrew Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200139432
    Abstract: A method of additive manufacturing is disclosed, comprising using a powder comprising a first particulate component (1) with a first mean particle diameter, and a second particulate component (2) with a second mean particle diameter. The first mean particle diameter is at least twice the second mean particle diameter. The particles (2) of the second component are bonded to the particles (1) of the first component, and the first and second components comprise different materials. The powder is deposited.
    Type: Application
    Filed: January 6, 2020
    Publication date: May 7, 2020
    Inventors: Adam Clare, Andrew Kennedy
  • Publication number: 20200131567
    Abstract: Methods of preparing double-stranded nucleic acids with single-stranded overhangs for amplification and sequencing are disclosed. Contacting a blunt-ended double-stranded nucleic acid molecules with Taq results in non-templated directed addition of a single nucleotide to the 3? ends of the nucleic acid with A added most frequently followed by G followed by C and T. G tailing is sufficiently frequent that the efficiency of ligation of nucleic acid molecules to adapters can be significantly increased by including adapters tailed with T and C. The ligation efficiency can be increased even further with blunted-ended adapters to ligate to blunt-ended nucleic acid molecules that failed to undergo tailing.
    Type: Application
    Filed: October 8, 2019
    Publication date: April 30, 2020
    Inventors: Andrew KENNEDY, Stefanie Ann Ward MORTIMER
  • Publication number: 20200131566
    Abstract: In an aspect, a method for evaluating the partitioning of nucleic acid molecules in a sample of polynucleotides based on epigenetic state, comprising: (a) adding a set of epigenetic-control nucleic acid molecules to the nucleic acid molecules in the sample of polynucleotides, whereby producing a spiked-in sample; (b) partitioning nucleic acid molecules of the spiked-in sample into plurality of partitioned sets; (c) enriching a subset of molecules from the plurality of partitioned sets to generate enriched molecules, wherein the enriched molecules comprises a group of epigenetic-control nucleic acid molecules and a group of nucleic acid molecules from the sample of polynucleotides; (d) sequencing the enriched molecules to produce sequencing reads; (e) analyzing the sequencing reads to generate one or more epigenetic partition scores of the epigenetic-control nucleic acid molecules; and (f) comparing the one or more epigenetic partition scores with one or more epigenetic partition cut-offs.
    Type: Application
    Filed: October 31, 2019
    Publication date: April 30, 2020
    Inventors: Andrew KENNEDY, Oscar WESTESSON, Yupeng He, Matthew SCHULTZ
  • Patent number: 10538750
    Abstract: This invention relates to reagents and methods for increasing specificity and efficiency of genome editing by CRISPR associated (Cas) protein systems, more particularly by Cas:guide RNA complexes, by blocking off-target nucleic acids from cleavage by Cas:guide RNA complexes.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: January 21, 2020
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Chong Wing Yung, Andrew Kennedy
  • Patent number: 10526590
    Abstract: The present invention relates to guide RNAs comprising adaptor segments having one or more modifications, and their use in homologous recombination by CRISPR:Cas systems. The modified adaptor segments are resistant to degradation by RNaseH. The present invention also relates to a dual guide RNA strategy in which a first guide RNA directs a Cas enzyme to make a double-strand break at a first target sequence, and a second guide RNA comprises an adaptor segment attached to a donor polynucleotide, and binds a second target sequence that is offset from the first target sequence.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: January 7, 2020
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Andrew Kennedy, Gusti Zeiner, Subhadeep Roy, Chong Wing Yung
  • Publication number: 20190390253
    Abstract: The disclosure provides methods for processing nucleic acid populations containing different forms (e.g., RNA and DNA, single-stranded or double-stranded) and/or extents of modification (e.g., cytosine methylation, association with proteins). These methods accommodate multiple forms and/or modifications of nucleic acid in a sample, such that sequence information can be obtained for multiple forms. The methods also preserve the identity of multiple forms or modified states through processing and analysis, such that analysis of sequence can be combined with epigenetic analysis.
    Type: Application
    Filed: June 24, 2019
    Publication date: December 26, 2019
    Inventors: Andrew KENNEDY, Stefanie Ann Ward MORTIMER, Helmy ELTOUKHY, AmirAli TALASAZ, Diana ABDUEVA, Matthew SCHULTZ
  • Publication number: 20190385700
    Abstract: Provided herein are methods that are useful in determining the cellular origin of cell-free nucleic acid (cfNA) fragments from cfNA samples, such as liquid biopsy samples. The methods disclosed herein typically improve the specificity and/or sensitivity of assays for detecting diseased cell nucleic acids (e.g., cancer cell DNA) in cfNA samples by identifying variant alleles produced by non-target cells, such as hematopoietic stem cells, in certain embodiments. Yet other aspects include related systems and computer readable media, among numerous other applications.
    Type: Application
    Filed: June 3, 2019
    Publication date: December 19, 2019
    Inventors: Ariel JAIMOVICH, Andrew KENNEDY, Justin I. ODEGAARD
  • Publication number: 20190085406
    Abstract: Disclosed herein are methods, compositions, and devices for use in early detection of cancer. The methods include sequencing a panel of regions in cell-free nucleic acid molecules and detecting one or more tumor markers that are indicative of a cancer.
    Type: Application
    Filed: April 14, 2017
    Publication date: March 21, 2019
    Inventors: Stefanie Ann Ward MORTIMER, AmirAli TALASAZ, Darya CHUDOVA, HELMY ELTOUKHY, Andrew KENNEDY
  • Patent number: 10226363
    Abstract: A prosthetic socket fitment system for fitting a prosthesis to a patient can include at least one transceiver assembly in contact with an external frame coupled to a patient, and a processing module in electrical communication with the at least one transceiver assembly. The at least one transceiver assembly can be aligned to the bone of the patient and configured to generate a signal directed to the bone of the patient and receive a reflected signal from the bone of the patient.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: March 12, 2019
    Assignees: University of Massachusetts, FTL Labs Corporation
    Inventors: Frank Charles Sup, IV, Andrew Kennedy LaPre, Michael White
  • Publication number: 20190011195
    Abstract: An external catalyst cooler arrangement for an FCC regenerator improves the operation of the catalyst cooler by the use of a heat removal unit design utilizing a central supply tube and central heat removal conduit surrounded by external heat removal tubes connected directly to the central heat removal conduit.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 10, 2019
    Applicant: Technip Process Technology, Inc.
    Inventors: Millard Alamath Carter, Andrew Kennedy Camille, Kenneth Fewel, Remus Ciobotaru, Bhumil Diwanji
  • Publication number: 20180305738
    Abstract: Methods of preparing double-stranded nucleic acids with single-stranded overhangs for amplification and sequencing are disclosed. Contacting a blunt-ended double-stranded nucleic acid molecules with Taq results in non-templated directed addition of a single nucleotide to the 3? ends of the nucleic acid with A added most frequently followed by G followed by C and T. G tailing is sufficiently frequent that the efficiency of ligation of nucleic acid molecules to adapters can be significantly increased by including adapters tailed with T and C. The ligation efficiency can be increased even further with blunted-ended adapters to ligate to blunt-ended nucleic acid molecules that failed to undergo tailing.
    Type: Application
    Filed: April 13, 2018
    Publication date: October 25, 2018
    Inventors: Andrew KENNEDY, Stefanie Ann Ward MORTIMER
  • Publication number: 20180141602
    Abstract: The present disclosure is directed to a bicycle parking structure comprising a plurality of bicycle hangers supported by a crossbar assembly. Each bicycle hanger is configured to support a bicycle in a substantially vertical position. The bicycle hangers are spaced apart from one another along the length of the crossbar assembly. Each of the bicycle hangers may be secured to the crossbar assembly so that the bicycle hanger is fixed at a desired position or unsecured from the crossbar assembly so that the position of the bicycle hanger along the length of the crossbar assembly may be adjusted. In this manner, the distance between adjacent bicycles need not be fixed and the bicycle parking structure can be adapted for a particular space. The bicycle parking structure is designed to provide for a space-efficient, high-volume parking of bicycles.
    Type: Application
    Filed: January 22, 2018
    Publication date: May 24, 2018
    Inventors: Joel Greenblatt, Andrew Kennedy Lageson
  • Patent number: 9932566
    Abstract: This invention discloses reagents and methods for increasing specificity and efficiency of RNA-guided genome editing.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: April 3, 2018
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Andrew Kennedy, Daniel E. Ryan
  • Patent number: 9908849
    Abstract: Imidamide (amidine) analogs that can inhibit the activity of sphingosine kinase 1 and sphingosine kinase 2 (SphK1 & SphK2) are provided. The compounds can prevent angiogenesis in tumors.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: March 6, 2018
    Assignee: University of Virginia Patent Foundation
    Inventors: Kevin R. Lynch, Timothy L. Macdonald, Thomas P. Mathews, Andrew Kennedy, Yugesh Kharel
  • Patent number: 9873472
    Abstract: The present disclosure is directed to a bicycle parking structure comprising a plurality of bicycle hangers supported by a crossbar assembly. Each bicycle hanger is configured to support a bicycle in a substantially vertical position. The bicycle hangers are spaced apart from one another along the length of the crossbar assembly. Each of the bicycle hangers may be secured to the crossbar assembly so that the bicycle hanger is fixed at a desired position or unsecured from the crossbar assembly so that the position of the bicycle hanger along the length of the crossbar assembly may be adjusted. In this manner, the distance between adjacent bicycles need not be fixed and the bicycle parking structure can be adapted for a particular space. The bicycle parking structure is designed to provide for a space-efficient, high-volume parking of bicycles.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: January 23, 2018
    Assignee: EVERLAST CLIMBING INDUSTRIES, INC.
    Inventors: Joel Greenblatt, Andrew Kennedy Lageson
  • Patent number: 9794172
    Abstract: A virtual edge router network for providing managed services to distributed remote office locations can include routing components that are capable of being autonomously deployed at the network edge, as well as remotely managed, thereby obviating the need for on-site technical support in remote offices of the a small and medium business (SMB) client. Autonomous deployment and remote management is achieved through abstraction of the control and management planes from the data plane. Virtual edge routers may include virtual forwarding units and virtual remote agents instantiated on host devices in each remote office location, as well as a virtual network controller instantiated on a host device in a head-office location. A data plane of the virtual edge router communicatively couples the virtual forwarding units to one another, while a control plane communicatively couples the virtual network controller to each virtual data forwarding unit.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: October 17, 2017
    Assignee: iPhotonix
    Inventors: Lance Arnold Visser, Louis Gregory Fausak, Andrew Kennedy Fullford, Eric Weeren, Russell Wiant, Richard Ballantyne Platt
  • Publication number: 20170247671
    Abstract: This invention relates to reagents and methods for increasing specificity and efficiency of genome editing by CRISPR associated (Cas) protein systems, more particularly by Cas:guide RNA complexes, by blocking off-target nucleic acids from cleavage by Cas:guide RNA complexes.
    Type: Application
    Filed: February 24, 2017
    Publication date: August 31, 2017
    Inventors: Chong Wing Yung, Andrew Kennedy
  • Patent number: 9688668
    Abstract: The invention relates to inhibitors of Sphingosine Kinase enzymatic activity, and methods of treating diseases and disorders by administering inhibitors of Sphingosine Kinase enzymatic activity.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: June 27, 2017
    Assignee: University of Virginia Patent Foundation
    Inventors: Webster L. Santos, Kevin R. Lynch, Timothy L. Macdonald, Andrew Kennedy, Yugesh Kharel, Mithun Rajendra Raje, Joseph Houck
  • Publication number: 20170166525
    Abstract: Imidamide (amidine) analogs that can inhibit the activity of sphingosine kinase 1 and sphingosine kinase 2 (SphK1 & SphK2) are provided. The compounds can prevent angiogenesis in tumors.
    Type: Application
    Filed: August 19, 2016
    Publication date: June 15, 2017
    Inventors: Kevin R. Lynch, Timothy L. Macdonald, Thomas P. Mathews, Andrew Kennedy, Yugesh Kharel
  • Publication number: 20170058298
    Abstract: The present invention relates to guide RNAs comprising adaptor segments having one or more modifications, and their use in homologous recombination by CRISPR:Cas systems. The modified adaptor segments are resistant to degradation by RNaseH. The present invention also relates to a dual guide RNA strategy in which a first guide RNA directs a Cas enzyme to make a double-strand break at a first target sequence, and a second guide RNA comprises an adaptor segment attached to a donor polynucleotide, and binds a second target sequence that is offset from the first target sequence.
    Type: Application
    Filed: August 30, 2016
    Publication date: March 2, 2017
    Inventors: Andrew Kennedy, Gusti Zeiner, Subhadeep Roy, Chong Wing Yung